OSCR has 36-month beta value of 1.64. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OSCR is 166.62M, and currently, short sellers hold a 4.58% ratio of that float. The average trading volume of OSCR on June 25, 2024 was 3.17M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
OSCR) stock’s latest price update
The stock of Oscar Health Inc (NYSE: OSCR) has decreased by -0.11 when compared to last closing price of 17.75. Despite this, the company has experienced a -5.69% fall in its stock price over the last five trading sessions. investorplace.com reported 2024-06-19 that Finding stocks with solid growth potential is essential to take advantage of new chances in today’s volatile market. These three exceptional firms each provide solid arguments for considering them as potential stocks to buy to double your money.
OSCR’s Market Performance
Oscar Health Inc (OSCR) has seen a -5.69% fall in stock performance for the week, with a -15.41% decline in the past month and a 31.33% surge in the past quarter. The volatility ratio for the week is 5.12%, and the volatility levels for the past 30 days are at 5.93% for OSCR. The simple moving average for the past 20 days is -8.40% for OSCR’s stock, with a 44.10% simple moving average for the past 200 days.
Analysts’ Opinion of OSCR
Many brokerage firms have already submitted their reports for OSCR stocks, with Robert W. Baird repeating the rating for OSCR by listing it as a “Outperform.” The predicted price for OSCR in the upcoming period, according to Robert W. Baird is $28 based on the research report published on May 30, 2024 of the current year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see OSCR reach a price target of $21, previously predicting the price at $25. The rating they have provided for OSCR stocks is “Neutral” according to the report published on May 30th, 2024.
Raymond James gave a rating of “Outperform” to OSCR, setting the target price at $20 in the report published on March 22nd of the current year.
OSCR Trading at -7.56% from the 50-Day Moving Average
After a stumble in the market that brought OSCR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.36% of loss for the given period.
Volatility was left at 5.93%, however, over the last 30 days, the volatility rate increased by 5.12%, as shares sank -13.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +20.83% upper at present.
During the last 5 trading sessions, OSCR fell by -5.27%, which changed the moving average for the period of 200-days by +170.26% in comparison to the 20-day moving average, which settled at $19.22. In addition, Oscar Health Inc saw 93.77% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OSCR starting from Blackley Richard Scott, who sale 29,978 shares at the price of $19.58 back on Jun 06 ’24. After this action, Blackley Richard Scott now owns 675,442 shares of Oscar Health Inc, valued at $586,969 using the latest closing price.
Quane Alessandrea C., the EVP, Chief Insurance Officer of Oscar Health Inc, sale 16,793 shares at $19.58 during a trade that took place back on Jun 06 ’24, which means that Quane Alessandrea C. is holding 251,136 shares at $328,807 based on the most recent closing price.
Stock Fundamentals for OSCR
Current profitability levels for the company are sitting at:
- -0.0 for the present operating margin
- 1.0 for the gross margin
The net margin for Oscar Health Inc stands at -0.01. The total capital return value is set at -0.02. Equity return is now at value -5.46, with -1.31 for asset returns.
Based on Oscar Health Inc (OSCR), the company’s capital structure generated 0.22 points at debt to capital in total, while cash flow to debt ratio is standing at -0.18. The debt to equity ratio resting at 0.29. The interest coverage ratio of the stock is -1.01.
Currently, EBITDA for the company is -235.62 million with net debt to EBITDA at 8.88. When we switch over and look at the enterprise to sales, we see a ratio of 0.25. The receivables turnover for the company is 10.09for trailing twelve months and the total asset turnover is 1.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.17.
Conclusion
To put it simply, Oscar Health Inc (OSCR) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
